UBS Group AG - LUX HEALTH TECH ACQUISITION ownership

LUX HEALTH TECH ACQUISITION's ticker is LUXA and the CUSIP is 55068A100. A total of 60 filers reported holding LUX HEALTH TECH ACQUISITION in Q4 2021. The put-call ratio across all filers is 0.22 and the average weighting 1.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of LUX HEALTH TECH ACQUISITION
ValueSharesWeighting
Q3 2022$48,000
-21.3%
4,781
-22.4%
0.00%
Q2 2022$61,000
-10.3%
6,158
-11.5%
0.00%
Q1 2022$68,000
+74.4%
6,956
+71.6%
0.00%
Q4 2021$39,000
-4.9%
4,053
-4.7%
0.00%
Q3 2021$41,000
-32.8%
4,252
-30.9%
0.00%
Q2 2021$61,000
-14.1%
6,152
-11.6%
0.00%
Q1 2021$71,0006,9580.00%
Other shareholders
LUX HEALTH TECH ACQUISITION shareholders Q4 2021
NameSharesValueWeighting ↓
Wolfswood Holdings, LLC 2,000,000$19,720,00081.59%
MYDA Advisors LLC 970,000$9,564,0003.78%
RP Investment Advisors LP 1,309,486$12,912,0001.81%
Tuttle Capital Management, LLC 41,697$411,0001.02%
Silver Rock Financial LP 369,442$3,643,0000.69%
Empyrean Capital Partners, LP 3,000,649$29,586,0000.65%
BBR PARTNERS, LLC 639,999$6,310,0000.60%
Governors Lane LP 725,000$7,149,0000.52%
Spartan Fund Management Inc. 226,753$2,795,0000.46%
Senator Investment Group LP 1,473,600$14,530,0000.45%
View complete list of LUX HEALTH TECH ACQUISITION shareholders